andrew-wakefield

Health Impact News Editor Comments

In what is perhaps the biggest news event of the year (that the mainstream media does not want to cover), the full ramifications of Dr. William Thompson of the CDC coming forward as a whistleblower to confess that the CDC has covered up data linking vaccines to autism are yet to be seen. (See: CDC Whistleblower: CDC Covered Up MMR Vaccine Link to Autism in African American Boys)

However, while blame and (hopefully) criminal complaints more than likely await many people who participated in this cover-up, there is one man who deserves honor, and to whom the mainstream media owes a huge apology: Dr. Andrew Wakefield.

Dr. Wakefield is the world-renowned gastrointestinal surgeon and researcher who has been accused of fraud and fabricating studies that show a link between the MMR vaccine and bowel disease, present in many children with autism. Dr. Wakefield was not an anti-vaccine doctor. Rather, he was a doctor interested in vaccine safety, and his studies led him (and many other researchers) to believe that there were problems with the three-combo vaccine of measles, mumps, and rubella (MMR). He did not advise his patients to stop vaccinating, but instead to vaccinate for these three diseases with single vaccines, rather than the combo.

There was just one problem with this advice. While this advice was in the best interest of parents seeking vaccine safety, it was not in the best interest of the manufacturer of the MMR vaccine (Merck), which saw a decline in its sales in the UK (although there was initially an increase in the sale of single-dose vaccines).

Dr. Wakefield’s research regarding the MMR vaccine and its link to bowel disease and autism was originally published in the Lancet. But a journalist by the name of Brian Deer published an article in the British Medical Journal criticizing Dr. Wakefield and accusing him of fraud. As a result, his study in the Lancet was retracted. Dr. Wakefield, and one of the co-authors of the retracted article, Prof. John Walker-Smith, were barred from practicing medicine by the United Kingdom’s General Medical Council regulatory board.

What you will not read in the mainstream media, however, is that both the BMJ and Lancet have strong financial ties to the manufacturer of the MMR vaccine. (See: BMJ & Lancet Wedded to Merck CME Partnership) You probably also did not read that Dr. Andrew’s co-author in the study,  Prof. John Walker-Smith, fought an expensive legal battle against the United Kingdom’s General Medical Council and won. He was completely exonerated

Dr. Andrew Wakefield, in the meantime, lost his career and name for simply following the truth his research led him to. He became the scapegoat, the “straw man” to knock down in the mainstream media. Every time someone would bring up any question regarding vaccines and autism you will usually encounter something like: “That theory has been totally proven false, and the guy who made it up was convicted of fraud.” I have even had people tell me on social media that “the guy” (most don’t even know his name) did “prison time.”

However, Dr. Wakefield was never convicted by a jury or in a court of law, and he lives in the U.S. today. He has issued challenges to his accusers to debate him in the media, but of course they have never accepted his challenge. He is a leading expert in gut health, a subject sorely needing research today, in an age where not only vaccines, but antibiotics, pesticides, and many other things have destroyed our ability to digest our food properly, leading to many bowel diseases. A list of his research, provided from his Facebook Page, is listed below.

If you want to know what people who personally know Dr. Wakefield think about him, read this report from one of the parents of two children that were part of his study that was allegedly “fabricated.” Dr. Wakefield was so successful in working with parents and children in in the U.K., helping them to find solutions to complicated health problems, that a British TV program was made dramatizing his work in the 1990s. It recently resurfaced on YouTube here.

UPDATE 9/5/2014: Judge: Lawsuit Against Merck’s MMR Vaccine Fraud to Continue

See Also:

CDC Vaccine Link to Autism Scandal: The Wrong Man was Condemned

Dr. Andrew Wakefield Exposes MMR Vaccine Fraud

Dr. Andrew Wakefield Issues Challenge to Public Debate Over U.K. Measles Outbreak

New Published Study Verifies Andrew Wakefield’s Research on Autism – Again

 

DR AJ WAKEFIELD

PUBLICATIONS 

Mant TG, Lewis JL, Mattoo TK, Rigden SP, VolansGN, House IM, Wakefield AJ, Cole RS.Mercury poisoning after disc-battery ingestion. HumToxicol. 1987:6:179-81.
          http://www.ncbi.nlm.nih.gov/pubmed/3557477

Silverman R, Cohen Z, Craig M, Wakefield A, Kim P, Langer B, Levy G. Monocyte/macrophage procoagulant activity (PCA) as ameasure of immune responsiveness in Lewis and Brown Norway inbred rats:discordance with lymphocyte proliferative assays. Transplantation 1989;47: 542-548.

http://www.ncbi.nlm.nih.gov/pubmed/2522255

Wakefield AJ, Gordon EM. A huge renal cystpresenting in childhood. Case report and review of the literature. Journalof the Royal Society of Medicine 1989; 82: 443-445.

http://www.ncbi.nlm.nih.gov/pubmed/2685309

Kim P,  Wakefield AJ, Cohen Z, Craig M, Levy G. The reversal of cyclosporine mediated suppression of alloantigen induced monocyteprocoagulant activity by H2 antagonists cimetidine and ranitidine invitro. Transplantation Proceedings 1989; 21: 844-847.

http://www.ncbi.nlm.nih.gov/pubmed/2705248

Kim P, Wakefield AJ, Cohen Z, Craig M,Levy G. The reversal of cyclosporine mediated suppression of monocyteprocoagulantactivity by H2 antagonists in a rat small intestinal transplantation model. Transplantation Proceedings 1989: 21;2900-2902.

http://www.ncbi.nlm.nih.gov/pubmed/2784921

Wakefield AJ, Cohen Z, Craig M, Jeejeebhoy KN, LevyGA. The thrombogenicity of total parenteral nutrition solutions. I: Effect oninduction of monocyte macrophage procoagulant activity.Gastroenterology1989; 97: 1210-1219.

http://www.ncbi.nlm.nih.gov/pubmed/2507384

Wakefield AJ, Cohen Z, Craig M, Rosenthal A,Gotleib A, Jeejeebhoy KN, Levy GA. The thrombogenicity of total parenteralnutrition solutions. II: Effect on induction of endothelial cell procoagulantactivity. Gastroenterology 1989; 97: 1220-1228.

http://www.ncbi.nlm.nih.gov/pubmed/2507385

Wakefield AJ, Sawyerr AM, Dhillon AP, Pittilo RM,Rowles PM, Lewis AAM, Pounder RE. Pathogenesis of Crohn’s disease: multifocalgastrointestinal infarction. Lancet 1989; ii: 1057-1062.

Sinclair S, Wakefield AJ, Levy GA Fulminanthepatic failure. Springer Seminars in Immunopathology, (ed) Thomas HC1990; 12: 33-45

Wakefield AJ, Cohen Z, Levy GA. Procoagulantactivity in Gastroenterology. Gut 1990; 31: 239-242.
Sawyerr AM, Wakefield AJ, Hudson M, Dhillon AP, Pounder RE. The pharmacological implications of leucocyte-endothelial cell interactions in Crohn’s disease. Alimentary Pharmacology & Therapeutics1991; 5: 1-14.

http://www.ncbi.nlm.nih.gov/pubmed/1681952

Wakefield AJ, Dhillon AP, Sawyerr AM, Sankey E,More, L, Sim R, Pittilo RM, Rowles PM, Hudson M, Lewis AAM, Pounder RE. Granulomatous vasculitis in Crohn’s disease. Gastroenterology 1991; 100:1279-1287.

http://www.ncbi.nlm.nih.gov/pubmed/2013373

Wakefield AJ, Sawyerr AM, Hudson M, Dhillon AP,Pounder RE. Smoking, the oral contraceptive pill and Crohn’s disease. Digestive Diseases & Sciences 1991; 36: 1147-1150.

http://www.ncbi.nlm.nih.gov/pubmed/1864207

Kelleher J, Wakefield AJ, Gordon I, RansleyP. Renal injury in complete ureteric obstruction: a functional and morphologicalstudy. Urological Research 1991; 19: 245-248.

http://www.ncbi.nlm.nih.gov/pubmed/1656580

Pounder RE, Wakefield AJ, Sawyerr AM, Hudson M, Dhillon AP. Pathogenesis of Crohn’s disease: granulomatous vasculitis andmultifocal gastrointestinal infarction Proceedings of the Falk Symposium on Inflammatory Bowel Disease 1991; 5: 33-38.

Kelleher JP, Shah V, Godley M, Wakefield AJ,Gordon I, Ransley PG, Snell ME, Risdon RA. Urinary endothelium (ET-1) incomplete ureteric obstruction in the miniature pig. Urological Research1992; 20: 63-65.

http://www.ncbi.nlm.nih.gov/pubmed/1736488

Wakefield AJ, Fox JD, Sawyerr AM, Taylor JE,Sweenie CH, Smith M, Emery V, Hudson M, Tedder RS, Pounder RE. Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn’s disease using the nested polymerase chain reaction. Journal of Medical Virology 1992; 38: 183-190.

http://www.ncbi.nlm.nih.gov/pubmed/1287131

Wakefield AJ, Hudson M, Pounder RE. Crohn’s Conflict (Invited article). Medical Laboratory World1992; 5: 9-1.

http://www.ncbi.nlm.nih.gov/pubmed/1287131

Hudson M, Piasecki C, Sankey EA, Sim R, Wakefield AJ, More LJ, Sawyerr AM, Dhillon AP, Pounder RE. A ferret model of acutemultifocal gastrointestinal infarction. Gastroenterology 1992; 102:1591-1596.

http://www.ncbi.nlm.nih.gov/pubmed/1568569

Dhillon AP, Anthony A, Sim R, Wakefield AJ, Sankey EA, Hudson M, Allison MC, Pounder RE. Mucosal capillary thrombi in rectal biopsies. Histopathology 1992; 21: 127-133.

http://www.ncbi.nlm.nih.gov/pubmed/1505929

Hudson M, Hutton R, Wakefield AJ, Sawyerr AM, Pounder RE. Evidence for activation of coagulation in Crohn’s disease. Blood Coagulation and Fibrinolysis 1992; 3: 773-778.

http://www.ncbi.nlm.nih.gov/pubmed/1489898

Hudson M, Wakefield AJ, Hutton RA, SankeyEA, Dhillon AP, More L, Sim R, Pounder RE. Factor XIIIa subunit and Crohn’s disease. Gut 1993; 34: 75-79.

http://www.ncbi.nlm.nih.gov/pubmed/8094363

Wakefield AJ, Hudson M, More L. Procoagulantactivity in gastroenterology. In: Procoagulant Activity in Health andDisease. Eds: Levy GA; Cole EH. CRC Press: Ann Arbor, USA. 1993; 5: 87-110.

http://www.ncbi.nlm.nih.gov/pubmed/7701246

SankeyEA, Dhillon AP, Anthony A, Wakefield AJ,Sim R, More L, Hudson M, Sawyerr AAM, Pounder RE. Early mucosal changes inCrohn’s disease. Gut 1993; 34: 375-381.

http://www.ncbi.nlm.nih.gov/pubmed/8472987

Osborne M, Hudson M, Piasecki C, Dhillon AP, Lewis AAM, Pounder RE, Wakefield AJ. Crohn’s disease andanastomotic recurrence: microvascular ischaemia and anastomotic healing in an animal model. British Journal of Surgery 1993; 80: 226-229.

http://www.ncbi.nlm.nih.gov/pubmed/8443664

Anthony A, Dhillon AP, Nygård G, Hudson M, Piasecki C, Strong P, Trevethick MA, Clayton NM, Jordan CC, Pounder RE, Wakefield AJ. Early histological features of small intestinal injury induced by indomethacin. Alimentary Pharmacology &.Therapeutics.1993; 7: 29-39.

Wakefield AJ, Pittilo RM, Sim R, Cosby SL,Stephenson JR, Dhillon AP, Pounder RE. Evidence of persistent measles virusinfection in Crohn’s disease. Journal of Medical Virology. 1993; 39:345-353.

Smith M, Wakefield AJ. Viral associationwith Crohn’s disease: Invited article. Annals of Medicine1993; 25:557-561.

More L, Sim R, Hudson M, Dhillon AP, Pounder RE, Wakefield AJ. Immunohistochemical study of tissue factor expression in normal intestine and idiopathic inflammatory bowel disease. Journal ofClinical Pathology 1993;46:703-708.

Wakefield AJ, More L, Difford J, McLaughlin JE.Immunohistochemical study of vascular injury in acute multiple sclerosis. Journalof Clinical Pathology 1994; 47: 129-133.

Hudson M, Piasecki C, Wakefield AJ, Sankey EA, Dhillon AP, Osborne M, Sim R, Pounder RE. A vascular hypersensitivity modelof acute multifocal intestinal infarction. Digestive Diseases & Sciences1994; 39: 534-539.

NygårdG, Anthony A, Piasecki C, Trevethick MA, Hudson M, Dhillon AP, Pounder RE, Wakefield AJ. Acuteindomethacin-induced jejunal injury in the rat: early morphological andbiochemical changes. Gastroenterology 1994; 106: 567-575.

Mazure G, Grundy JE, Nygård G, Hudson M, Khan K, Srai K, Dhillon AP, Pounder RE, Wakefield AJ. Measles virus inductionof human endothelial cell tissue factor procoagulant activity in vitro.Journal of General Virology1994; 75: 2863-2871.

  1. HamiltonMI, Wakefield AJ. Inflammatory boweldisease. Recent Advances in Gastroenterology. Vol.10 Ed. RE Pounder.Churchill Livingstone. London 1994. Vol. 10 9.pp 161-180.
  2. ThompsonNP, Wakefield AJ. Infective agents-Vascular factors Inflammatory Bowel Disease. Ed. Allan RN, KeighleyMRB, Rhodes J. Alexander Williams J. 1994;17:133-142.
  3. EkbomA, Wakefield AJ, Zack M, Adami H-O.Perinatal measles infection and subsequent Crohn’s disease. Lancet 1994;344: 508-510.
  4. SawyerrAM, Pottinger BE, Savage CO, Bradley NJ, Hudson M, Wakefield AJ, Pearson JD, Pounder RE. Serum immunoglobulin Greactive with endothelial cells in inflammatory bowel disease. DigestiveDiseases & Sciences 1994; 39: 1909-1917.
  5. AnthonyA, Dhillon AP, Sim R, Pounder RE, WakefieldAJ. Dexamethasone promotes ulcer plugging in experimental enteritis. AlimentaryPharmacol & Therapeutics 1994; 8: 597-602.
  6. SmithM, Wakefield AJ. Crohn’s disease:ancient and modern. Invited article. Journal of Postgraduate Medicine.1994; 70: 149-153.
  7. AnthonyA, Dhillon AP, Sim R, Nygård G, Pounder RE, Wakefield AJ. Ulceration, fibrosis and diaphragm-like lesions inthe caecum of rats treated with Indomethacin Alimentary Pharmacology &Therapeutics 1994; 8: 417-424.
  8. Wakefield AJ. The pathogenesis of Crohn’s disease. ChronicInflammatory Bowel Disease. Stangė E F (Ed), Kluwer Academic Publishers,London, 1994, pp 22-29.
  9. Wakefield AJ, Hudson M, Pounder RELeukocyte-endothelial cell interactions in Crohn’s disease: potential targetsfor mesalazine in Crohn’s disease.Advances in Experimental Medicine andBiology 1995. Ed: McGhee JR and Mestecky J. Plenum Press, NewYork:1307-1311.
  10. RayRA, Smith M, Sim R, Nystrom M, Pounder R E, Wakefield AJ. The intracellular polymerase chain reaction for smallCMV genomic sequences within heavily infected cellular sections. Journal ofPathology 1995; 177:171-180.
  11. RayRA, Smith M, Sim R, Bruce I, WakefieldAJIn situ hybridisationdetection of short viral amplicon sequences within cultured cells and bodyfluids after the in situ polymerasechain reaction. Journal of Virological Methods 1995; 52: 247-263.
  12. NygårdG, Hudson M, Mazure G, Anthony A, Dhillon AP, Pounder RE, Wakefield AJProcoagulant and prothrombotic response of humanendothelium to indomethacin and endotoxin invitro: relevance to non-steroidal inflammatory drug enteropathy.ScandinavianJournal of Gastroenterol. 1995; 30: 25-32.
  13. NygårdG, Anthony A, Khan K, Bounds SV, Dhillon AP, Pounder RE, Wakefield AJ. Intestinal site-dependent susceptibility to chronicindomethacin in the rat: a morphological and biochemical study. AlimentaryPharmacology & Therapeutics 1995; 9: 403-410.
  14. Wakefield AJ, Ekbom A, Dhillon AP, Pittilo RM,Pounder RE. Crohn’s disease: pathogenesis and persistent measles virusinfection. Gastroenterology 1995; 108: 911-916.
  15. ThompsonN, Wakefield AJ, Pounder RE.Inherited disorders of coagulation appears to protect against inflammatorybowel disease. Gastroenterology 1995; 108: 1011-1015.
  16. HamiltonMI, Dick R, Crawford L, Thompson NP, Pounder RE, Wakefield AJ. Is proximal demarcation of ulcerative colitisdetermined by the territory of the inferior mesenteric artery?Lancet1995; 345: 688-690.
  17. HamiltonMI, Bradley NJ, Srai SKS, Thrasivoulou C, Pounder RE, Wakefield AJ.Autoimmunity in ulcerative colitis: tropomyosin isnot the major antigenic determinant of the Das monoclonal antibody, 7E12H12. Clinical& Experimental Immunology.1995; 99: 404-411.
  18. ThompsonNP, Wakefield AJ, Pounder RE.Prognosis and prognostic risk factors in inflammatory bowel disease. Specialarticle. Saudi Journal of Gastroenterology. 1995;1:129-137.
  19. LewinJ, Dhillon AP, Sim R, Pounder RE, WakefieldAJ. Persistent measles virus infection of the intestine: confirmation byimmunogold electron microscopy. Rapid publication. Gut 1995; 36: 564-569.
  20. ThompsonNP, Montgomery SM, Pounder RE, WakefieldAJ. Is measles vaccination a risk factor for inflammatory bowel disease? Lancet1995; 345: 1071-1074.
  21. AnthonyA, Dhillon AP, Thrasivoulou C, Pounder RE, WakefieldAJ. Pre-ulcerative villus contraction and microvascular occlusion inducedby indomethacin in the rat jejunum: a detailed morphological study. AlimentaryPharmacology & Therapeutics. 1995;9:605-613.
  22. AnthonyA, Dhillon AP, Fidler H, McFadden JJ, Billington O, Nygård G, Pounder RE,Wakefield AJ. Mycobacterial granulomatousinflammation in the ulcerated caecum of indomethacin-treated rats. InternationalJournal of Experimental Pathology. 1995; 76: 149-155.
  23. SmithMS, Warren BF, Fox JD, Watkins PE, Hudson M, Pounder RE, Wakefield AJ.Detection of herpesvirus DNA in cotton-top tamarins:no association with colitis. International Journal of Experimental Pathology.1995;76:201-203.
  24. SawyerrAM, Smith MS, Hall A, Hudson M, Hay CR, WakefieldAJ, Brook MG, Tomura H, Pounder RE. Serum concentrations of von Willebrandfactor and soluble thrombomodulin indicate alteration of endothelial functionin inflammatory bowel diseases. Digestive Diseases & Sciences. 1995;40: 793-799.
  25. Wakefield AJ. Vasculitis and Crohn’s disease: anovel and debated concept. Research and Clinical Forums. 1995; 17: 53-56.
  26. Wakefield AJ. Crohn’s disease – the pathogenesis ofa granulomatous vasculitis: A hypothesis. Canadian Journal ofGastroenterology 1995; 9: 199-202.
  27. RayR, Cooper PJ, Wakefield AJ. The eraof intracellular nucleic acid technology.Biotechnology. 1995; 13:445-447.
  28. ThompsonNP, Pounder RE, Wakefield AJ. Perinataland childhood risk factors for inflammatory bowel disease: a case-controlstudy. European Journal of Gastroenterology and Hepatology. 1995; 7:385-390
  29. Wakefield AJ, Pounder RE. Measles virus in Crohn’sdisease (letter). Lancet 1995;345;660.
  30. AnthonyA, Sim R, Dhillon AP, Pounder RE, WakefieldAJ. Gastric mucosal contraction and vascular injury induced by indomethacinprecede neutrophil infiltration in the rat. Gut 1996; 39: 363-368.
  31. EkbomA, Daszak PS, Kraaz W, Wakefield AJ.Crohn’s disease following measles virus exposure in utero: risk estimates and clinical characteristics. Lancet1996; 344: 508-509.
  32. RayR, Cooper PJ, Sim R, Chadwick N, Earle P, Dhillon AP, Pounder RE, Wakefield AJ.Direct in situ reverse transcriptase polymerasechain reaction for detection of measles virus.Journal of VirologicalMethods 1996;60:1-17.
  33. AnthonyA, Bahl A, Oakley IG, Spraggs CF, Dhillon AP, Trevethick MA, Piasecki C,Pounder RE, Wakefield AJ. The beta-3adrenoceptor agonist CL316243 prevents indomethacin-induced jejunal ulcerationin the rat by reversing early villous shortening. Journal of Pathology1996:179:340-346.
  34. HudsonM, Chitolie A, Hutton RA, Smith MS, Pounder RE, Wakefield AJ. Thrombotic vascular risk factors in inflammatorybowel disease. Gut 1996;38:733-737.
  35. RayR, Sim R, Khan K, Dhillon AP, Pounder RE, WakefieldAJ. Direct in situ nucleic acidamplification: control of artifact and use of labelled primers. ClinicalMolecular Pathology1996; 49: 345-350.
  36. ThompsonN, Driscoll R, Pounder RE, Wakefield AJ.Genetics versus environment in inflammatory bowel disease: results of aBritish twin study. British Medical Journal 1996; 312: 95-96.
  37. ThompsonNP, Fleming DM, Pounder RE, WakefieldAJ. Crohn’s disease, measles and measles vaccination: a case-controlfailure (letter). Lancet 1996;347:263.
  38. WalmsleyRS, Zhao MH, Hamilton MI, Brownlee A, Chapman P, Pounder RE, Wakefield AJ,Lockwood CM.Antineutrophil cytoplasm autoantibodies against bactericidal/permeability increasingprotein in inflammatory bowel disease. Gut 1997;40:105-109.
  39. DaszakP, Purcell M, Lewin J, Dhillon AP, Pounder RE, Wakefield AJ. Detection and comparative analysis of persistentmeasles virus infection in Crohn’s disease by immunogold electron microscopy. Journalof Clinical Pathology 1997;50:299-304.
  40. Wakefield AJ, Sim R, Akbar AN, Pounder RE, DhillonAP. In situ immune responses inCrohn’s disease: a comparison with acute and persistent measles virusinfection. Journal of Medical Virology. 1997;51:90-100.
  41. AnthonyA, Dhillon AP, Pounder RE, Wakefield AJ.Ulceration of the ileum in Crohn’s disease: correlation with vascularanatomy. Journal of Clinical Pathology.1997;50:1013-1017.
  42. AnthonyA, Pounder RE, Dhillon AP, Wakefield AJ.Vascular anatomy defines sites of indomethacin-induced jejunal ulceration alongthe mesenteric margin. Gut 1997;41:763-770.
  43. MontgomerySM & Wakefield AJ. Measlesvaccine and neurological events. Lancet 1997; 349: 1625 (letter)
  44. MontgomerySM, Pounder RE, Wakefield AJ. Infantmortality and the incidence of inflammatory bowel disease. Lancet 1997;349: 472-473.
  45. MontgomerySM, Morris DL, Pounder RE, Wakefield AJ.Measles vaccination and inflammatory bowel disease (letter). Lancet1997;350:1774.
  46. TiwanaH, Wilson C, Walmsley RS, Wakefield AJ,Smith MSH, Cox NL, Hudson MJ, Ebringer A. Antibody responses to gut bacteria inankylosing spondylitis, rheumatoid arthritis, Crohn’s disease and ulcerativecolitis. Rheumatology International. 1997; 17: 11-16.
  47. Wakefield AJ, Murch SH, Anthony A, Linnell J, CassonDM, Malik M, Berelowitz M, Dhillon AP, Thomson MA, Harvey P, Valentine A,Davies SE, Walker-Smith JA. Ileal lymphoid nodular hyperplasia, non-specificcolitis and pervasive developmental disorder in children.Lancet1998;351:637-641 (Retracted: applied for reinstatement).
  48. KellyDA, Piasecki C, Anthony A, Dhillon AP, Pounder RE, Wakefield AJ. Focal reduction of villous blood flow in earlyindomethacin enteropathy: a dynamic vascular study in the rat.Gut1998;42:366-373.
  49. MontgomerySM, Morris DL, Thompson NP, Subhani J, Pounder RE, Wakefield AJ.Prevalence of inflammatory bowel disease in British26-year olds. British Medical Journal1998;7137:1058-1059.
  50. BalzolaF, Khan K, Pera, A, Bonino F, Pounder RE, WakefieldAJ. Measles IgM immunoreactivity in patients inflammatory bowel disease. ItalianJournal of Gastroenterol.1998;30:4,378-382.
  51. TiwanaH, Walmsley RS, Wilson C, Yiannakou JY, Ciclitira PJ, Wakefield AJ, Ebringer A. Characterisation of the Humoral ImmuneResponse to Klebsiella Species inInflammatory Bowel Disease and Ankylosing Spondylitis. British Journal ofRheumatology. 1998:37;525-531.
  52. AnthonyA, Schepelmann S, Guillaume J-L, Strosberg AD, Dhillon AP, Pounder RE,Wakefield AJ. Localisation of the beta3-adrenoceptorin the human gastrointestinal tract: an immunohistochemical study. AlimentaryPharmacology & Therapeutics. 1998;12:579-526.
  53. ChadwickN, Bruce I, Davies M, van Gemen B, Schukkink R, Khan K, Pounder RE,Wakefield AJ. A sensitive and robustmethod for measles RNA detection. Journal of Virological Methods.1998,70:59-67.
  54. ChadwickN, Bruce IJ, Schepelmann S, Pounder RE, WakefieldAJ. Measles virus RNA is not detected in inflammatory bowel disease usinghybrid capture and reverse transcription followed by the polymerase chainreaction. Journal of Medical Virology, 1998;55:305-311.
  55. WalmsleyRS, Anthony A, Sim R, Pounder RE, WakefieldAJ. Absence of E. Coli, Listeriaand Klebsiella pneumoniae withininflammatory bowel disease tissues. Journal of Clinical Pathology.1998;51:657-661.
  56. KellyD, Piaseki C, Anthony, A, Dhillon AP, Ponder RE, Wakefield AJ. Reversal and protection against indomethacin-inducedblood stasis and mucosal damage in the rat jejunum by a B-3 adrenoceptoragonist. Alimentary Pharmacology & Therapeutics. 1998; 12:1121-1129.
  57. Wakefield AJ & Montgomery SM. Crohn’s disease:the case for measles virus (Invited article) Italian Journal ofGastroenterology 1999;31:247-254.
  58. ChadwickN, Wakefield AJ, Pounder RE, BruceI. A comparison of three nucleic acid amplification methods as a source for DNAsequencing. BioTechniques 1998;25:818-822.
  59. MontgomerySM, Morris DL, Pounder RE, Wakefield AJ.Paramyxivorus infections in childhood and subsequent inflammatory boweldisease. Gastroenterology 1999;116:796-803.
  60. TompsonNP, Fleming DM, Charlton J, Pounder RE, WakefieldAJ. Patients Consulting with Crohn’s disease in primary care in England andWales. European Journal of Gastroenterology & Hepatology.1998;10:1007-1012.
  61. AnthonyA, Dhillon AP, Pounder RE, Wakefield AJ.The colonic mesenteric margin is most susceptible to injury in an experimentalmodel of colonic ulceration. Alimentary Pharmacology & Therapeutics. 1999;13:531-535.
  62. AnthonyA, Sim R, Pounder RE, Dhillon AP, WakefieldAJ. Similarities between Crohn’s disease and indomethacin experimentalulcers in the rat. Alimentary Pharmacology and Therpeutics.2000;14:241-24.
  63. MontgomerySM, Twamley SI, Murch SH, Pounder RE, WakefieldAJ Contact with soil in infancy does not protect against atopy. ImmunologyToday 1999;20:289-290.
  64. MontgomerySM, Morris DL, Pounder RE, Wakefield AJ.Asian ethnic origin and the risk of inflammatory bowel disease. European.Journalof Gastroenterology and Hepatology.1999;11:543-546.
  65. MontgomerySM, Pounder RE, Wakefield AJ.Smoking in adults and passive smoking in children are associated with acuteappendicitis. Lancet 1999;353:379.
  66. MontgomerySM, Wakefield AJ, Morris DL, PounderRE, Murch SH. The initial care of newborn infants and subsequent hay fever. Allergy.2000;;55:916-22.
  67. Orteu CH, McGregor JM, Whittaker SJ, Balzola F, Wakefield AJ. Erythema elevatum diutinum and Crohndisease: a common pathogenic role for measles virus? Arch Dermatol.1996;32:1523-5.
  68. Wakefield AJ, Anthony A, Murch SH, Thomson M,Montgomery SM, Davies S, Walker-Smith JA. Enterocolitis in children withdevelopmental disorder. American Journal of Gastroenterology2000;95:2285-2295 (Retracted: applied for reinstatement).
  69. FurlanoRI, Anthony A, Day R, Brown A, McGavery L, Thomson MA, Davies SE, Berelowitz M,Forbes A, Wakefield AJ, Walker-SmithJA, Murch SH. Colonic CD8 and gamma delta T-cell infiltration with epithelialdamage in children with autism. Journal of Pediatrics2001;138:366-72.
  70. Wakefield AJ and Montgomery SM. Autism, viralinfection and measles mumps rubella vaccination. Israeli Medical AssociationJournal 1999;1:183-187.
  71. DunnAC, Walmsley RS, Dedrick RL, WakefieldAJ, Lockwood CM. Anti-neutrophil cytoplasmic autoantibodies (ANCA) tobactericidal/permeability-increasing (BPI) protein recognize the carboxylterminal domain. Journal of Infection. 1999;39:81-7.
  72. Thompson NP., Montgomery SM., Wadsworth MEJ., Pounder RE., Wakefield AJ. Early determinants ofinflammatory bowel disease: use of two longitudinal birth cohorts.EuropeanJournal of Gastroenterology & Hepatology. 2000;12:25-30.
  73. Kawashima H., Takayuki M., Kashiwagi Y., Takekuma K., Hoshika A., Wakefield AJ. Detection and sequencingof measles virus from peripheral blood mononuclear cells from patients withinflammatory bowel disease and autism. Digestive Diseases and Sciences.2000;45:723-729.
  74. Wakefield AJ and Montgomery SM. Measles, mumps,rubella vaccine: through a glass, darkly. Adverse Drug Reactions &Toxicological Reviews 2000;19:265-283.
  75. MorrisDL, Montgomery SM, Galloway ML, Pounder RE,Wakefield AJ. Inflammatory bowel disease and laterality: is left handednessa risk? Gut. 2001;49:199-202.
  76. Wakefield AJ,Montgomery SM. Immunohistochemical analysis of measles related antigen inInflammatory bowel disease. Gut. 2001;48:136-7.
  77. Morris DL,Montgomery SM, Thompson NP, Ebrahim S, Pounder RE, Wakefield AJ. Measles vaccination and inflammatory bowel disease: anational British Cohort Study. American Journal of Gastroenterology.2000;95:3507-12.
  78. O’Leary JJ,Uhlmann V, Wakefield AJ. Measlesvirus and autism. Lancet. 2000;356:772 (letter).
  79. Wakefield AJ,Montgomery SM. Measles virus as a risk for inflammatory bowel disease: anunusually tolerant approach. American Journal of Gastroenterology.2000;95:1389-92. (Editorial).
  80. Anthony A, SimR, Guillaume JL, Strosberg AD, Dhillon AP, Pounder RE, Wakefield AJ. Beta (beta)3-adrenergic receptors in human pancreaticislet and duodenal somatostatin neuroendocrine cells. AlimentaryPharmacology and Therapeutics. 2000;14:579-8.
  81. Kelly D, AnthonyA, Piasecki C, Lewin J, Pounder RE, WakefieldAJ. Endothelial changes precede mucosal ulceration induced by indomethacin:an experimental study in the rat.Alimentary Pharmacology and Therapeutics.2000;14:489-96.
  82. Wakefield AJ.MMR vaccination and autism. Lancet. 1999;354:949-50 (letter).
  83. Wakefield AJ.The New Autism (Invited Article) Clinical Child Psychology & Psychiatry  2002;7:518-528.
  84. UhlmannV., Martin C, Shiels, Wakefield AJ,O.Leary JJ. Possible viral pathogenesis of a novel paediatric inflammatory boweldisease. Molecular Pathology 2002;55:84-90.
  85. Wakefield AJ.,Puleston J. Montgomery SM., Anthony A., O’Leary J.J., Murch SH Entero-colonicencephalopathy, autism and opioid receptor ligands. Alimentary Pharmacology& Therapeutics. 2002;16:663-674.
  86. Torrente F.,Machado N., Perez-Machado M., Furlano R., Thomson M., Davies S., Wakefield AJ, Walker-Smith JA, MurchSH. Enteropathy with T cell infiltration and epithelial IgG deposition inautismMolecular Psychiatry.2002;7:375-382.
  87. Montgomery SM,Wakefield AJ, Ekbom A. Pertussisinfection in childhood and type I diabetes 2002 Diabet. Med. 2002;19:986–993.
  88. MontgomerySM., Lambe M., Wakefield AJ.,Pounder RE., Ekbom A. Siblings and the risk of Inflammatory Bowel Disease. ScandinavianJournal of Gastroenterology 2002;37:1301-1308.
  89. Wakefield AJ.The Gut-Brain Axis in Childhood developmental Disorders. Journal ofPediatric Gastroenterology and Nutrition. 2002;34:S14-S17.
  90. Wakefield AJ. Entero-colitis,Autism and Measles Virus. Consensus in Child Neurology.2002;6:74-77.
  91. AshwoodP, Anthony A, Pellicer AA, Torrente F, WakefieldAJ. Intestinal lymphocyte populations in children with regressive autism:Evidence for extensive mucosal immunopathology. Journal of ClinicalImmunology, 2003;23:504-517.
  92. Wakefield AJ. Enterocolitis, autism and measlesvirus. Molecular Psychiatry. 2002;7:S44-46
  93. Ashwood P, Anthony A, Torrente F, Wakefield AJ., Spontaneous mucosallymphocyte cytokine profiles in children with regressive autism andgastrointestinal symptoms: Mucosal immune activation and reduced counterregulatory interleukin-10. Journal of Clinical Immunology.2004:24:664-673.
  94. Anthony A, Ashwood P., Wakefield AJ. The significance ofileo-colonic lymphoid nodular hyperplasia in children with autistic spectrumdisorder. European Journal of Gastroenterology and Hepatology 2005 Aug;17(8):827-36.
  95. BradstreetJJ, ,El Dahr J., Anthony A., Kartzinel J., WakefieldAJ, Detection of Measles Virus Genomic RNA in Cerebrospinal Fluid ofChildren with Regressive Autism: a Report of Three Cases   Journal ofAmerican Physicians and Surgeons. 2004.9:39-45.
  96. StottC., Blaxill M., Wakefield AJ. MMR and Autism in Perspective:the Denmark Story.Journalof American Physicians and Surgeons 2004;9:89-91.
  97. The Gut-Brain Axisin Childhood Developmental Disorders: Viruses and Vaccines. Wakefield AJ., Collins I., Ashwood P.  Invited chapter in Infectious Disease andNeuropsychiatric Disorders Chapter 21, pp 198-206
  98. AshwoodP, Wakefield AJ. Ileal andperipheral blood CD3+ cytokine profiles in children with regressive autism andgastrointestinal symptoms: Mucosal immune activation and reduced counterregulatoryinterleukin-10. Journal of Neuroimmunology. 2006 ;73:126-34.
  99. Wakefield AJ., Stott C., Limb K. Gastrointestinal co-morbidity,autistic regression and Measles-containing vaccines: positive re-challenge andbiological gradient effects. Medical Veritas2006;3:796-802
  100. Wakefield AJ. The significance ofileocolonic lymphoid nodular hyperplasia in children with autistic spectrumdisorder. (letter) Eur J Gastro Hep 2006;18:571-574.
  101. Wakefield AJ. Autistic enterocolitis: is it ahistopathological entity? Histopathology 2006;50:380-384.
  102. Russo AJ,Krigsman A, Jepson B, Wakefield AJ.Anti-PR3 and Anti-MPO IgG ANCA in Autistic Children With Chronic GI Disease. Immunologyand Immunogenetics Insights 2009:2:21-28.
  103. Russo AJ,Krigsman A, Jepson B, Wakefield A. Lowserum alpha-1 antitrypsin associated with anti-PR-3 ANCA in autistic childrenwith GI disease. – Genomics Insights, 2009 2009;2:1–9.
  104. Russo AJ,Krigsman A, Jepson B, Wakefield AJ.Decreased Serum Hepatocyte Growth Factor (HGF) in Autistic Children with SevereGastrointestinal Disease. Biomarker Insights. 2009; 4: 181–190.
  105. Russo AJ,Krigsman A, Jepson B, Wakefield AJ.Generalized Autoimmunity of ANCA and ASCA Related to Severity of Disease inAutistic Children with GI Disease. Immunology and Immunogenetics Insights2009:1 37–47.
  106. Wakefield AJ.Callous Disregard. Autism and Vaccines – The Truth Behind a Tragedy. New York(2010) Skyhorse Publishing.
  107. Wakefield AJ.Waging war on the Autistic Child. The Arizona 5 and the Legacy of Baron vonMunchausen. New York (2012) Skyhorse Publishing.
  108. Russo AJ,Krigsman, A, Jepson B, Wakefield AJ.Low serum myeloperoxidase in autistic children with gastro-intestinal disease.Clin Exp Gastroenterol. 2009; 2:85-94.
  109. Wakefield AJ,Blaxill M, Haley B, Ryland A, Hollenbeck D, Johnson J, Moody J, Stott C. Response to Dr. Ari Brown and The Immunization Action Coalition. Medical Veritas6 2009; 6: 1907–1924

 

Dissolving Illusions: Disease, Vaccines, and The Forgotten History
by Dr. Suzanne Humphries and Roman Bystrianyk

Cover

Free Shipping Available!
Learn More